Enantia is a Barcelona-based Contract Research Organisation (CRO) specialising in advanced chemistry solutions for pharmaceutical, biotech, and material science industries.

Full Company Description

Founded in 2003 and headquartered in the Barcelona Science Park, Enantia has established itself as a leader in providing tailored chemical and medicinal research services. With expertise in medicinal chemistry, chemical R&D, and solid-state R&D, the company supports drug discovery, process development, and scale-up solutions. Their cutting-edge technologies and a highly skilled team enable collaborations with global organisations to solve complex chemical challenges. Enantia is also renowned for its work in asymmetric synthesis and cocrystallisation.

Key Products and Services

• Medicinal Chemistry: Drug discovery support through design and synthesis of small molecules targeting various therapeutic areas.
• Chemical R&D: Synthesis route design, impurity profiling, and process optimisation for pharmaceutical and fine chemical industries.
• Solid-State R&D: Comprehensive solid-form services, including screening, analysis, characterisation, and long-term stability studies.
• Cannabinoids: Proprietary technology for synthetic cannabinoids and purification of natural extracts.
• Highly Potent APIs: Capabilities for developing solid forms of highly potent compounds.

With a strong commitment to innovation and sustainability, Enantia continues to push the boundaries of chemistry services. Their dedication to fostering successful partnerships and delivering high-quality solutions makes them a trusted partner for the pharmaceutical and biotechnology sectors worldwide.